359
Views
13
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLES

Adherence to oral bisphosphonates: 30 more minutes in dosing instructions matter

, , , , , , & show all
Pages 608-616 | Received 09 Jun 2014, Accepted 02 Dec 2014, Published online: 24 Feb 2015

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Barbora Vankova, Katerina Mala-Ladova, Ales Antonin Kubena, Josef Maly & Sylvie Dusilova Sulkova. (2018) Immunosuppressive therapy related adherence, beliefs and self-management in kidney transplant outpatients. Patient Preference and Adherence 12, pages 2605-2613.
Read now
Tereza Touskova, Magda Vytrisalova, Vladimir Palicka, Tereza Hendrychova, Leos Fuksa, Radka Holcova, Jana Konopacova & Ales Antonin Kubena. (2015) Drug holidays: the most frequent type of noncompliance with calcium plus vitamin D supplementation in persistent patients with osteoporosis. Patient Preference and Adherence 9, pages 1771-1779.
Read now

Articles from other publishers (11)

Enrique Casado, José Rosas, Carlos Rubio-Terrés, Darío Rubio-Rodríguez, Mitra Boolell & Ignacio Arístegui. (2023) Cost–effectiveness of weekly gastro-resistant risedronate 35 mg, compared with weekly alendronate 70 mg tablets, in the treatment of postmenopausal osteoporosis in Spain. Journal of Comparative Effectiveness Research 12:11.
Crossref
John A. Eisman, Bernard Cortet, Mitra Boolell, Raluca Ionescu-Ittu, Francis Vekeman, Julie Heroux & Friederike Thomasius. (2023) Fracture risk in women with osteoporosis initiated on gastro-resistant risedronate versus immediate release risedronate or alendronate: a claims data analysis in the USA. Osteoporosis International 34:5, pages 977-991.
Crossref
Asma Radwan, Naser Shraim, Josephean Elaraj, Anwar Hamad, Dana Fatayer, Bayan Jarar, Ayoub Johar & Areen Zriqah. (2022) Knowledge and compliance towards alendronate therapy among postmenopausal women with osteoporosis in Palestine. BMC Women's Health 22:1.
Crossref
Nicholas Fuggle, Nasser Al-Daghri, Olivier Bock, Jaime Branco, Olivier Bruyère, Enrique Casado, Etienne Cavalier, Bernard Cortet, Maarten de Wit, Andrea Giusti, Philippe Halbout, Nicholas C. Harvey, Mickaël Hiligsmann, Jean-Marc Kaufman, Andreas Kurth, Stefania Maggi, Radmila Matijevic, Salvatore Minisola, Santiago Palacios, Régis Pierre Radermecker, Friederike Thomasius, Sansin Tuzun, Nicola Veronese, John A. Kanis, Jean-Yves Reginster, René Rizzoli & Cyrus Cooper. (2022) Novel formulations of oral bisphosphonates in the treatment of osteoporosis. Aging Clinical and Experimental Research 34:11, pages 2625-2634.
Crossref
Diane Kleinermans, Andrew Joyson & Heather Wray. (2022) An open‐label randomized study of the relative absorption of gastro‐resistant risedronate taken fasted or with food versus immediate‐release risedronate. Pharmacology Research & Perspectives 10:3.
Crossref
Friederike Thomasius, Santiago Palacios, Asif Alam, Mitra Boolell, Francis Vekeman & Geneviève Gauthier. (2021) Fracture rates and economic outcomes in patients with osteoporosis prescribed risedronate gastro-resistant versus other oral bisphosphonates: a claims data analysis. Osteoporosis International 33:1, pages 217-228.
Crossref
Ondřej Tesař, Veronika Měrková, Martin Doseděl & Josef Malý. (2020) Food as an important part of maximizing the effect and minimizing the risks of pharmacotherapy - absorption and gastrointestinal tolerance. Klinická farmakologie a farmacie 34:3, pages 108-115.
Crossref
Klára Boruzs, Viktor Dombrádi, János Sándor, Gábor Bányai, Robert Horne, Klára Bíró & Attila Nagy. (2020) Cross-Cultural Adaptation and Lingual Validation of the Beliefs about Medicines Questionnaire (BMQ)-Specific for Cholesterol Lowering Drugs in the Visegrad Countries. International Journal of Environmental Research and Public Health 17:20, pages 7616.
Crossref
Yet H. Khor, Ian Glaspole & Nicole S.L. Goh. (2019) Therapeutic burden in interstitial lung disease: Lessons to learn. Respirology 24:6, pages 566-571.
Crossref
Petra Matalová. (2019) Osteoporosis - 2nd part, pharmacotherapy. Interní medicína pro praxi 21:1, pages 14-19.
Crossref
Stuart L. Silverman & Deborah T. Gold. 2018. Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism. Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism 593 596 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.